BLOOD RESEARCH

The Korean Society of Hematology (대한혈액학회)
권호 표지
DOI QR코드

DOI QR Code

Statistics of hematologic malignancies in Korea: incidence, prevalence and survival rates from 1999 to 2008

  • Park, Hyeon Jin (Center for Pediatric Oncology, National Cancer Center) ;
  • Park, Eun-Hye (The Korea Central Cancer Registry, Division of Cancer Registration and Surveillance, National Cancer Center) ;
  • Jung, Kyu-Won (The Korea Central Cancer Registry, Division of Cancer Registration and Surveillance, National Cancer Center) ;
  • Kong, Hyun-Joo (The Korea Central Cancer Registry, Division of Cancer Registration and Surveillance, National Cancer Center) ;
  • Won, Young-Joo (The Korea Central Cancer Registry, Division of Cancer Registration and Surveillance, National Cancer Center) ;
  • Lee, Joo Young (The Korea Central Cancer Registry, Division of Cancer Registration and Surveillance, National Cancer Center) ;
  • Yoon, Jong Hyung (Center for Pediatric Oncology, National Cancer Center) ;
  • Park, Byung-Kiu (Center for Pediatric Oncology, National Cancer Center) ;
  • Lee, Hyewon (Center for Specific Organs Cancer, National Cancer Center) ;
  • Eom, Hyeon-Seok (Center for Specific Organs Cancer, National Cancer Center) ;
  • Park, Sohee (The Korea Central Cancer Registry, Division of Cancer Registration and Surveillance, National Cancer Center)
  • Received : 2012.03.03
  • Accepted : 2012.03.19
  • Published : 2012.03.31
⟨ Previous Next ⟩

Abstract

Background The nationwide statistical analysis of hematologic malignancies in Korea has not been reported yet. Methods The Korea Central Cancer Registry and the Korean Society of Hematology jointly investigated domestic incidence rates and prevalence of hematologic malignancies occurred between 1999 and 2008, and analyzed survival rates of patients who were diagnosed between 1993 and 2008. Data of hematologic malignancies from 1993 to 2008 were obtained from the Korean National Cancer Incidence Data base. The crude incidence rates, age-specific incidence rates, age-standardized incidence rates, annual percentage change of incidence, and prevalence from 1999-2008 were calculated. Survival rates for patients diagnosed in 1993-2008 were estimated. Results In 2008, a total of 8,006 cases of hematologic malignancies were occurred, which comprised 4.5% of all malignancies. In all genders, non-Hodgkin lymphoma, myeloid leukemia, and multiple myeloma were most frequent diseases. In terms of age, ages between 60 and 69 were most prevalent. From 1999 to 2008, the age-standardized incidence rates increased from 10.2 to 13.7, and the annual percentage change was 3.9%. The 5-year survival rate increased from 38.2% during 1993-1995 to 55.2% during 2004-2008. As of January 2009, number of patients with 10-year prevalence was 33,130, and with 5- to 10-year prevalence was 10,515. Conclusion This is the first nationwide statistical report of hematologic malignancies in Korea. It could be used as the basic information to help investigate epidemiologic characteristics, evaluate progress during the past years, and establish future strategies for hematologic malignancies. Periodic statistical analysis of hematologic malignancies in Korea should be continued.

Keywords

Cited by

  1. The premier statistical report of hematologic malignancies in Korea vol.47, pp.1, 2012, https://doi.org/10.5045/kjh.2012.47.1.1
  2. Epidemiologic overview of malignant lymphoma vol.47, pp.2, 2012, https://doi.org/10.5045/kjh.2012.47.2.92
  3. 동종 조혈모세포이식을 받은 환자에서 운동중재의 효과 vol.12, pp.3, 2012, https://doi.org/10.5388/aon.2012.12.3.195
  4. The Role of Radiotherapy for the Treatment of Gastric MALT Lymphoma vol.83, pp.6, 2012, https://doi.org/10.3904/kjm.2012.83.6.712
  5. Prognostic implications of tumor extent in early-stage diffuse large B-cell lymphoma vol.97, pp.2, 2013, https://doi.org/10.1007/s12185-013-1260-9
  6. High-dose chemotherapy and autologous stem-cell transplantation in Korean patients with relapsed or refractory Hodgkin lymphoma vol.97, pp.2, 2012, https://doi.org/10.1007/s12185-013-1267-2
  7. Chronic lymphocytic leukemia in Korean patients: frequent atypical immunophenotype and relatively aggressive clinical behavior vol.97, pp.3, 2012, https://doi.org/10.1007/s12185-013-1286-z
  8. Autologous stem cell transplantation in light-chain amyloidosis patients: a single-center experience in Korea vol.20, pp.4, 2012, https://doi.org/10.3109/13506129.2013.824417
  9. Immunophenotypic Characterization and Quantification of Neoplastic Bone Marrow Plasma Cells by Multiparametric Flow Cytometry and Its Clinical Significance in Korean Myeloma Patients vol.28, pp.4, 2013, https://doi.org/10.3346/jkms.2013.28.4.542
  10. Overview of Cancer Registration Research in the Asian Pacific from 2008-2013 vol.14, pp.8, 2013, https://doi.org/10.7314/apjcp.2013.14.8.4461
  11. Cancer Incidence in Southwest of Iran: First Report from Khuzestan Population-Based Cancer Registry, 2002-2009 vol.14, pp.12, 2012, https://doi.org/10.7314/apjcp.2013.14.12.7517
  12. Diagnosed hematological malignancies in Bangladesh - a retrospective analysis of over 5000 cases from 10 specialized hospitals vol.14, pp.None, 2012, https://doi.org/10.1186/1471-2407-14-438
  13. Brentuximab vedotin for relapsed or refractory CD30+ Hodgkin lymphoma: a multicenter analysis from Asia vol.7, pp.None, 2012, https://doi.org/10.2147/ott.s67380
  14. The Role of Radiotherapy in the Treatment of Gastric Mucosa-Associated Lymphoid Tissue Lymphoma vol.46, pp.1, 2012, https://doi.org/10.4143/crt.2014.46.1.33
  15. Clinical Outcome of Bortezomib Retreatment in Patients with Relapsed or Refractory Multiple Myeloma vol.2014, pp.None, 2012, https://doi.org/10.1155/2014/145843
  16. Cancer Incidence and Survival among Adolescents and Young Adults in Korea vol.9, pp.5, 2012, https://doi.org/10.1371/journal.pone.0096088
  17. Association of nitric oxide synthase 3 (NOS3) 894？G>T polymorphism with prognostic outcomes of anthracycline in Chinese patients with acute myeloid leukaemia vol.41, pp.6, 2012, https://doi.org/10.1111/1440-1681.12235
  18. Health-related quality of life in Korean lymphoma survivors compared with the general population vol.93, pp.9, 2014, https://doi.org/10.1007/s00277-014-2091-3
  19. Association of ABCB1 polymorphisms with prognostic outcomes of anthracycline and cytarabine in Chinese patients with acute myeloid leukemia vol.71, pp.3, 2012, https://doi.org/10.1007/s00228-014-1795-6
  20. Use of lenalidomide in the management of relapsed or refractory multiple myeloma: expert recommendations in Korea vol.50, pp.1, 2012, https://doi.org/10.5045/br.2015.50.1.7
  21. Research Trends in Evidence-Based Medicine: A Joinpoint Regression Analysis of More than 50 Years of Publication Data vol.10, pp.4, 2012, https://doi.org/10.1371/journal.pone.0121054
  22. Bortezomib-Based Salvage Chemotherapy in Refractory/Relapsed Multiple Myeloma Patients: A Single Center Experience in Real Clinical Practice vol.88, pp.5, 2012, https://doi.org/10.3904/kjm.2015.88.5.537
  23. Gender and ethnic differences in incidence and survival of lymphoid neoplasm subtypes in an Asian population: Secular trends of a population‐based cancer registry from 1998 to 2012 vol.137, pp.11, 2012, https://doi.org/10.1002/ijc.29635
  24. Leukemia in Iran: Epidemiology and Morphology Trends vol.16, pp.17, 2012, https://doi.org/10.7314/apjcp.2015.16.17.7759
  25. Consortium for Improving Survival of Lymphoma (CISL): a model of multicenter collaboration for lymphoma studies in Korea vol.50, pp.4, 2012, https://doi.org/10.5045/br.2015.50.4.187
  26. Nationwide statistical analysis of myeloid malignancies in Korea: incidence and survival rate from 1999 to 2012 vol.50, pp.4, 2015, https://doi.org/10.5045/br.2015.50.4.204
  27. Incidence, Survival and Prevalence Statistics of Classical Myeloproliferative Neoplasm in Korea vol.31, pp.10, 2012, https://doi.org/10.3346/jkms.2016.31.10.1579
  28. Treatment outcomes and clinical relevance of the Follicular Lymphoma International Prognostic Index in Korean follicular lymphoma patients treated with chemotherapy vol.31, pp.3, 2012, https://doi.org/10.3904/kjim.2014.222
  29. Gradual increase of chronic lymphocytic leukemia incidence in Korea, 1999-2010: comparison to plasma cell myeloma vol.57, pp.3, 2016, https://doi.org/10.3109/10428194.2015.1068307
  30. A Case of Coexistence of Bone Marrow-involved Refractory Marginal Zone B-Cell Lymphoma and Therapy-related Myelodysplastic Syndrome vol.6, pp.2, 2012, https://doi.org/10.3343/lmo.2016.6.2.98
  31. Incidence Trend for Non-Hodgkin Lymphoma in the North Tunisian Population, 1998-2009 vol.17, pp.5, 2016, https://doi.org/10.7314/apjcp.2016.17.5.2513
  32. Circulating immune cell phenotype can predict the outcome of lenalidomide plus low-dose dexamethasone treatment in patients with refractory/relapsed multiple myeloma vol.65, pp.8, 2016, https://doi.org/10.1007/s00262-016-1861-2
  33. Distribution and features of hematological malignancies in Eastern Morocco: a retrospective multicenter study over 5 years vol.16, pp.None, 2016, https://doi.org/10.1186/s12885-016-2205-5
  34. 급성 림프모구성 백혈병 소아, 청소년의 유지 항암치료 시점 별 신체적 증상과 심리, 사회적 증상, 활동 및 교육 실태 vol.16, pp.4, 2012, https://doi.org/10.5388/aon.2016.16.4.169
  35. Clinical outcomes in patients with diffuse large B cell lymphoma with a partial response to first-line R-CHOP chemotherapy: prognostic value of secondary International Prognostic Index scores and Deau vol.96, pp.11, 2012, https://doi.org/10.1007/s00277-017-3107-6
  36. Trend and treatment patterns of aplastic anemia in Korea, pure red cell aplasia and myelodysplastic syndrome in Korea: a nation-wide analysis vol.106, pp.4, 2017, https://doi.org/10.1007/s12185-017-2280-7
  37. Adverse prognostic impact of vascular endothelial growth factor gene polymorphisms in patients with diffuse large B-cell lymphoma vol.58, pp.11, 2012, https://doi.org/10.1080/10428194.2017.1300893
  38. Prevalence and cumulative 5-year incidence of chronic lymphocytic leukemia in the adult population in the Russian Federation and Ukraine: Data from the LEUKOSPECT study vol.22, pp.1, 2012, https://doi.org/10.1080/10245332.2016.1201630
  39. Validation of the Korean Version of the Quality of Life–Cancer Survivors (QOL-CS-K) Questionnaire in Lymphoma Survivors vol.50, pp.1, 2012, https://doi.org/10.4143/crt.2017.091
  40. Nationwide Statistical Analysis of Lymphoid Malignancies in Korea vol.50, pp.1, 2012, https://doi.org/10.4143/crt.2017.093
  41. Complete metabolic response (CMR) in positron emission tomography–computed tomography (PET‐CT) scans may have prognostic significance in patients with marginal zone lymphomas (MZL) vol.36, pp.1, 2012, https://doi.org/10.1002/hon.2414
  42. Monozygotic twins with shared de novo GATA2 mutation but dissimilar phenotypes due to differential promoter methylation vol.60, pp.4, 2012, https://doi.org/10.1080/10428194.2018.1516039
  43. Combining deep-inspiration breath hold and intensity-modulated radiotherapy for gastric mucosa-associated lymphoid tissue lymphoma: Dosimetric evaluation using comprehensive plan quality indices vol.14, pp.1, 2012, https://doi.org/10.1186/s13014-019-1263-7
  44. The Effect of Disability on the Diagnosis and Treatment of Multiple Myeloma in Korea: A National Cohort Study vol.52, pp.1, 2020, https://doi.org/10.4143/crt.2018.702
  45. Distinct clinical characteristics at diagnosis in patients with late relapses compared with early relapses of diffuse large B-cell lymphoma treated with R-CHOP vol.61, pp.5, 2012, https://doi.org/10.1080/10428194.2019.1709831
  46. Clinical Characteristics and Risk Factors for Pleural Effusion in Patients with Multiple Myeloma vol.14, pp.None, 2012, https://doi.org/10.2147/ijgm.s300337
  47. Association of serum free thyroxine and glucose homeostasis: Korea National Health and Nutrition Examination Survey vol.36, pp.suppl1, 2012, https://doi.org/10.3904/kjim.2019.160
  48. Asia‐inclusive global development of pevonedistat: Clinical pharmacology and translational research enabling a phase 3 multiregional clinical trial vol.14, pp.3, 2012, https://doi.org/10.1111/cts.12972
  49. Spectrum of lymphoma subtypes based on the latest World Health Organization classification in southern Iran from 2000 to 2011 vol.17, pp.34, 2012, https://doi.org/10.2217/fon-2020-0534